Maternal Height-standardized Prevalence of Stunting in 67 Low- and Middle-income Countries.
low and middle-income countries
maternal height
prevalence of stunting
undernutrition
Journal
Journal of epidemiology
ISSN: 1349-9092
Titre abrégé: J Epidemiol
Pays: Japan
ID NLM: 9607688
Informations de publication
Date de publication:
05 07 2022
05 07 2022
Historique:
pubmed:
23
2
2021
medline:
9
7
2022
entrez:
22
2
2021
Statut:
ppublish
Résumé
Prevalence of stunting is frequently used as a marker of population-level child undernutrition. Parental height varies widely in low- and middle-income countries (LMIC) and is also a major determinant of stunting. While stunting is a useful measure of child health, with multiple causal components, removing the component attributable to parental height may in some cases be helpful to identify shortcoming in current environments. We estimated maternal height-standardized prevalence of stunting (SPS) in 67 LMICs and parental height-SPS in 20 LMICs and compared with crude prevalence of stunting (CPS) using data on 575,767 children under-five from 67 Demographic and Health Surveys (DHS). We supplemented the DHS with population-level measures of other child health outcomes from the World Health Organization's (WHO) Global Health Observatory and the United Nations' Inter-Agency Group for Child Mortality Estimation. Prevalence of stunting was defined as percentage of children with height-for-age falling below -2 z-scores from the median of the 2006 WHO growth standard. The average CPS across countries was 27.8% (95% confidence interval [CI], 27.5-28.1%) and the average SPS was 23.3% (95% CI, 23.0-23.6%). The rank of countries according to SPS differed substantially from the rank according to CPS. Guatemala, Bangladesh, and Nepal had the biggest improvement in ranking according to SPS compared to CPS, while Gambia, Mali, and Senegal had the biggest decline in ranking. Guatemala had the largest difference between CPS and SPS with a CPS of 45.2 (95% CI, 43.7-46.9%) and SPS of 14.1 (95% CI, 12.6-15.8%). Senegal had the largest increase in the prevalence after standardizing maternal height, with a CPS of 28.0% (95% CI, 25.8-30.2%) and SPS of 31.6% (95% CI, 29.5-33.8%). SPS correlated better than CPS with other population-level measures of child health. Our study suggests that CPS is sensitive to adjustment for maternal height. Maternal height, while a strong predictor of child stunting, is not amenable to policy interventions. We showed the plausibility of SPS in capturing current exposures to undernutrition and infections in children.
Sections du résumé
BACKGROUND
Prevalence of stunting is frequently used as a marker of population-level child undernutrition. Parental height varies widely in low- and middle-income countries (LMIC) and is also a major determinant of stunting. While stunting is a useful measure of child health, with multiple causal components, removing the component attributable to parental height may in some cases be helpful to identify shortcoming in current environments.
METHODS
We estimated maternal height-standardized prevalence of stunting (SPS) in 67 LMICs and parental height-SPS in 20 LMICs and compared with crude prevalence of stunting (CPS) using data on 575,767 children under-five from 67 Demographic and Health Surveys (DHS). We supplemented the DHS with population-level measures of other child health outcomes from the World Health Organization's (WHO) Global Health Observatory and the United Nations' Inter-Agency Group for Child Mortality Estimation. Prevalence of stunting was defined as percentage of children with height-for-age falling below -2 z-scores from the median of the 2006 WHO growth standard.
RESULTS
The average CPS across countries was 27.8% (95% confidence interval [CI], 27.5-28.1%) and the average SPS was 23.3% (95% CI, 23.0-23.6%). The rank of countries according to SPS differed substantially from the rank according to CPS. Guatemala, Bangladesh, and Nepal had the biggest improvement in ranking according to SPS compared to CPS, while Gambia, Mali, and Senegal had the biggest decline in ranking. Guatemala had the largest difference between CPS and SPS with a CPS of 45.2 (95% CI, 43.7-46.9%) and SPS of 14.1 (95% CI, 12.6-15.8%). Senegal had the largest increase in the prevalence after standardizing maternal height, with a CPS of 28.0% (95% CI, 25.8-30.2%) and SPS of 31.6% (95% CI, 29.5-33.8%). SPS correlated better than CPS with other population-level measures of child health.
CONCLUSION
Our study suggests that CPS is sensitive to adjustment for maternal height. Maternal height, while a strong predictor of child stunting, is not amenable to policy interventions. We showed the plausibility of SPS in capturing current exposures to undernutrition and infections in children.
Identifiants
pubmed: 33612705
doi: 10.2188/jea.JE20200537
pmc: PMC9189321
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
337-344Références
Acta Paediatr Suppl. 2006 Apr;450:7-15
pubmed: 16817674
Soc Sci Med. 1998 Nov;47(9):1231-46
pubmed: 9783866
Soc Sci Med. 2019 Oct;238:112374
pubmed: 31345611
Adv Nutr. 2019 Mar 1;10(2):196-204
pubmed: 30801614
J Nutr. 2015 Dec;145(12):2705-14
pubmed: 26446481
Lancet Child Adolesc Health. 2019 Dec;3(12):855-870
pubmed: 31542357
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Am J Hum Biol. 2005 Jan-Feb;17(1):5-21
pubmed: 15611967
Soc Sci Med. 2019 Oct;238:112486
pubmed: 31470245
JAMA. 2010 Apr 21;303(15):1507-16
pubmed: 20407060
Am J Phys Anthropol. 2018 Apr;165(4):834-854
pubmed: 29574837
Demography. 2009 Feb;46(1):1-25
pubmed: 19348106
Nutr Rev. 2016 Mar;74(3):149-65
pubmed: 26928678
Am J Hum Biol. 2015 Jul-Aug;27(4):494-500
pubmed: 25573763
Epigenomics. 2011 Apr;3(2):221-34
pubmed: 22122283
Int J Epidemiol. 2012 Dec;41(6):1602-13
pubmed: 23148108
JAMA. 2009 Apr 22;301(16):1691-701
pubmed: 19383960
PLoS One. 2013 May 29;8(5):e64636
pubmed: 23734210
Matern Child Nutr. 2013 Sep;9 Suppl 2:58-68
pubmed: 24074318
Am J Hum Biol. 2020 May;32(3):e23383
pubmed: 31889376
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13232-7
pubmed: 17686991